Iqbal Sahar, Ijaz Aamir, Sharafat Shaheen
Department of Pathology, Dow International Medical College, Dow University of Health Sciences, Karachi.
Department of Pathology, AFIP, Rawalpindi.
J Pak Med Assoc. 2017 May;67(5):701-705.
To estimate relative expanded uncertainty measurement of routine clinical chemistry analytes for international organisation for standardisation 15189 accreditation.
This cross-sectional study was conducted at Dow International Medical College, Karachi, from September 2013 to May 2014. During the process of international organisation for standardisation 15189 accreditation, measurement uncertainty was estimated for 13 clinical chemistry analytes using top-down approach. Relative combined uncertainty of each analyte was calculated by combining uncertainties of imprecision, bias and calibrators. Results of estimated imprecision, bias and expanded uncertainties were observed for allowable imprecision, bias and total analytical error for the respective analyte..
Uncertainties of imprecision were found within acceptable limits for all analytes except total protein (2.4% vs. 1.3%). Uncertainties of bias of all analytes were found within allowable limits. Relative expended uncertainties of all analytes were found acceptable except total protein (4.7%vs 3.63%).
The approach used to estimate the measurement uncertainty may be found simple and feasible by clinical laboratories interested in getting the relevant accreditation.
为获得国际标准化组织15189认可,估算常规临床化学分析物的相对扩展不确定度测量值。
本横断面研究于2013年9月至2014年5月在卡拉奇的陶氏国际医学院进行。在国际标准化组织15189认可过程中,采用自上而下的方法对13种临床化学分析物的测量不确定度进行了估算。通过合并不精密度、偏倚和校准物的不确定度,计算每种分析物的相对合成不确定度。观察到各分析物的估计不精密度、偏倚和扩展不确定度结果,以及各自分析物的允许不精密度、偏倚和总分析误差。
除总蛋白外(2.4%对1.3%),所有分析物的不精密度不确定度均在可接受范围内。所有分析物的偏倚不确定度均在允许范围内。除总蛋白外(4.7%对3.63%),所有分析物的相对扩展不确定度均可接受。
对于有兴趣获得相关认可的临床实验室而言,用于估算测量不确定度的方法可能简单可行。